how many mg of tirzepatide should i start with Microdosing Chart: A Weekly Dose Guide That Works Tirzepatide Dosage Chart: Complete Dosing

As the first FDA-approved dual incretin receptor agonist, tirzepatide serves as a key reference compound for GIP/GLP-1 synergy research and a benchmark for emerging triple agonist compounds including retatrutide

Hjberg PV, Vilsbll T, Rabol R, Knop FK, Bache M, Krarup T, Holst JJ, Madsbad S

Clinical Trial Results The most recent head-to-head study showed tirzepatide provided 47% greater relative weight loss compared to semaglutide

Great results no side effects Works well

High-dose users (12.5 to 15mg) should commit to a full 30-day washout, possibly extending to 35 days if they experienced significant GI side effects on tirzepatide

Not intended for human or veterinary use